India’s Path To Universal Health Care Outlined In Lancet Paper Ahead Of Budget 2026 – BW Healthcare World
A recent paper published in The Lancet has outlined a roadmap for India to achieve universal health care by 2030, with a focus on the upcoming Budget 2026. The paper, titled “India’s path to universal health coverage: a call to action,” highlights the country’s progress towards achieving universal health care and identifies key areas that require attention and investment.
The authors of the paper note that India has made significant strides in improving health outcomes in recent years, with a decline in infant and maternal mortality rates, and an increase in life expectancy. However, despite these gains, the country still faces significant health challenges, including a high burden of non-communicable diseases, inadequate healthcare infrastructure, and a shortage of healthcare professionals.
To address these challenges, the paper recommends that the Indian government increase its investment in healthcare to at least 2.5% of the country’s GDP by 2025, with a focus on strengthening primary healthcare, improving healthcare infrastructure, and enhancing the skills of healthcare professionals. The authors also emphasize the need for a more equitable and inclusive healthcare system, with a focus on reaching marginalized and vulnerable populations.
The paper identifies several key areas that require attention and investment in the upcoming Budget 2026, including:
- Strengthening primary healthcare: The authors recommend increasing investment in primary healthcare, including the expansion of health and wellness centers, and the deployment of more community health workers.
- Improving healthcare infrastructure: The paper highlights the need for significant investment in healthcare infrastructure, including the construction of new hospitals, the upgrading of existing facilities, and the procurement of medical equipment.
- Enhancing the skills of healthcare professionals: The authors recommend increasing investment in the training and development of healthcare professionals, including doctors, nurses, and community health workers.
- Expanding health insurance coverage: The paper emphasizes the need to expand health insurance coverage to all citizens, with a focus on marginalized and vulnerable populations.
Overall, the paper provides a comprehensive roadmap for India to achieve universal health care by 2030, with a focus on strengthening primary healthcare, improving healthcare infrastructure, and enhancing the skills of healthcare professionals. The authors emphasize the need for significant investment in healthcare in the upcoming Budget 2026, and highlight the importance of a more equitable and inclusive healthcare system that reaches all citizens, regardless of their income or social status.
Glenmark introduces emergency epinephrine injection – Drug Store News
Glenmark Pharmaceuticals has launched an epinephrine injection, which is the first FDA-approved generic version of Auvi-Q, according to a report by Drug Store News. The epinephrine injection, also known as epinephrine injection, USP, is a prescription medication used to treat life-threatening allergic reactions, including anaphylaxis.
The medication is available in a pre-filled syringe and is administered via intramuscular injection, typically in the middle of the outer thigh. It is designed to provide fast and effective relief from severe allergic reactions, which can be caused by a range of allergens, including food, insect stings, and latex.
The launch of the epinephrine injection by Glenmark is significant, as it provides patients with a more affordable alternative to branded products. The list price of Glenmark’s epinephrine injection is expected to be lower than that of Auvi-Q, making it a more accessible option for patients who require this life-saving medication.
Glenmark’s epinephrine injection has been approved by the FDA in two doses: 0.3mg and 0.15mg. The 0.3mg dose is intended for patients who weigh 30kg or more, while the 0.15mg dose is intended for patients who weigh between 15kg and 30kg. The medication is available in a carton of two auto-injectors, each containing a single dose of epinephrine.
The launch of Glenmark’s epinephrine injection is an important development for patients who are at risk of anaphylaxis. Anaphylaxis is a severe and potentially life-threatening allergic reaction that requires immediate medical attention. Symptoms of anaphylaxis can include difficulty breathing, rapid heartbeat, and a drop in blood pressure. If left untreated, anaphylaxis can lead to serious health consequences, including death.
Glenmark’s epinephrine injection provides patients with a reliable and effective treatment option for anaphylaxis. The medication has undergone rigorous testing and has been shown to be safe and effective in clinical trials. With its launch, Glenmark is helping to expand access to this critical medication, making it more widely available to patients who need it.
Overall, the launch of Glenmark’s epinephrine injection is a significant development in the treatment of anaphylaxis. The medication provides patients with a fast and effective treatment option for severe allergic reactions, and its availability is expected to improve health outcomes for patients who are at risk of anaphylaxis.
Several major Indian pharmaceutical companies, including Sun Pharma, Cipla, Zydus, and Graviti, have issued recalls for certain medications in the United States market.
Several major pharmaceutical companies, including Sun Pharma, Cipla, Zydus, and Graviti Pharmaceuticals, are recalling various products in the US due to manufacturing issues, according to recent US FDA enforcement reports. The recalls are primarily related to problems with impurities, quality control, and production processes.
Sun Pharma is recalling over 24,000 bottles of Fluocinolone Acetonide topical solution and Clindamycin Phosphate topical solution due to out-of-specification results for impurities and assay. Cipla is recalling more than 15,000 syringes of Lanreotide Injection, used to treat a rare hormonal condition, due to production issues at its Greek manufacturing partner, Pharmathen. The production of Lanreotide has been temporarily paused to address quality concerns, resulting in limited supply.
Additionally, Cipla is recalling over 92,000 tubes of Diclofenac Sodium Topical Gel due to failed pH specifications. Graviti Pharmaceuticals is recalling over 4,000 bottles of Furosemide Tablets due to the presence of a foreign substance. Zydus Pharmaceuticals is recalling over 22,000 bottles of Icosapent Ethyl capsules due to oxidation caused by leakage, which may lead to inconsistent therapeutic effects and increased gastrointestinal side effects.
These recalls highlight the importance of quality control and manufacturing standards in the pharmaceutical industry. The FDA’s enforcement actions aim to ensure that products meet strict safety and efficacy standards to protect public health. The recalls may result in temporary shortages of these products, and patients are advised to consult their healthcare providers for alternative treatments.
The recalls also underscore the need for pharmaceutical companies to maintain robust quality control systems and adhere to good manufacturing practices (GMPs) to prevent such issues. The companies involved are taking corrective actions to address the problems and prevent future occurrences. The FDA will continue to monitor the situation and take further action if necessary to ensure the safety and efficacy of pharmaceutical products in the US market.
According to Apollo doctor, adopting three key lifestyle modifications can significantly safeguard cardiovascular well-being and reduce the risk of developing high blood pressure naturally.
High blood pressure, or hypertension, is a significant risk factor for cardiovascular disease, which is the leading cause of death worldwide. According to the World Health Organization (WHO), approximately 1.13 billion people globally suffer from hypertension, and this number is expected to increase to 1.5 billion by 2025. In an effort to mitigate this risk, a doctor from Apollo Hospital has recommended three essential lifestyle changes to protect heart health and naturally lower the risk of high blood pressure.
Firstly, the doctor emphasizes the importance of maintaining a healthy diet. A well-balanced diet rich in fruits, vegetables, whole grains, and lean proteins can help regulate blood pressure. Specifically, the doctor recommends consuming foods that are high in potassium, such as bananas, leafy greens, and sweet potatoes, as potassium helps to lower blood pressure by balancing out the effects of sodium in the body. Additionally, reducing sodium intake and limiting the consumption of processed and packaged foods is crucial in maintaining healthy blood pressure levels.
Secondly, regular physical activity is vital for heart health. Engaging in at least 150 minutes of moderate-intensity aerobic exercise, such as brisk walking, cycling, or swimming, or 75 minutes of vigorous-intensity aerobic exercise, such as running or HIIT (High-Intensity Interval Training), per week can significantly lower blood pressure. The doctor also recommends incorporating strength training exercises into one’s routine, as this can help improve overall cardiovascular health and reduce the risk of hypertension.
Lastly, managing stress is essential for maintaining healthy blood pressure levels. Chronic stress can lead to increased blood pressure, and the doctor recommends practicing stress-reducing techniques such as meditation, yoga, or deep breathing exercises. Getting adequate sleep, ideally 7-8 hours per night, is also crucial in regulating blood pressure and overall cardiovascular health.
In conclusion, making these three lifestyle changes can significantly reduce the risk of high blood pressure and promote overall heart health. By adopting a balanced diet, engaging in regular physical activity, and managing stress, individuals can naturally lower their blood pressure and reduce their risk of cardiovascular disease. The doctor emphasizes that these changes are simple yet effective and can be incorporated into one’s daily routine with minimal effort. By taking control of one’s lifestyle, individuals can take a proactive approach to protecting their heart health and reducing their risk of hypertension.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.